Table 7.
95% CI |
||||||
---|---|---|---|---|---|---|
Outcome | Predictor | B | p | Lower | Upper | r |
| ||||||
Observed Emotional | Intercept | 2.44 | <.001 | 1.20 | 3.68 | − |
Support at 6-Months | Prenatal Support Provision | 0.20 | .02 | 0.03 | 0.36 | .14 |
Prenatal Actor PE | 0.19 | .054 | −0.003 | 0.39 | .11 | |
Prenatal Partner PE | −0.03 | .79 | −0.22 | 0.16 | .01 | |
Gender | −0.16 | .68 | −0.90 | 0.59 | .03 | |
Prenatal Actor PE x Gender | −0.05 | .60 | −0.26 | 0.15 | .03 | |
Prenatal Partner PE x Gender | 0.09 | .39 | −0.11 | 0.29 | .05 | |
| ||||||
Outcome | Predictor | B | p | Lower | Upper | r |
| ||||||
Observed Instrumental | Intercept | 2.51 | <.001 | 1.32 | 3.69 | − |
Support at 6-Months | Prenatal Support Provision | 0.20 | .02 | 0.04 | 0.36 | .14 |
Prenatal Actor PE | 0.15 | .16 | −0.06 | 0.35 | .09 | |
Prenatal Partner PE | −0.01 | .92 | −0.20 | 0.18 | .01 | |
Gender | −0.29 | .48 | −1.08 | 0.51 | .06 | |
Prenatal Actor PE x Gender | 0.07 | .52 | −0.14 | 0.27 | .04 | |
Prenatal Partner PE x Gender | −0.01 | .95 | −0.20 | 0.19 | .00 | |
| ||||||
Outcome | Predictor | B | p | Lower | Upper | r |
| ||||||
Observed Negative | Intercept | 5.21 | <.001 | 4.31 | 6.10 | − |
Support at 6-Months | Prenatal Support Provision | −0.12 | .04 | −0.24 | −0.01 | .13 |
Prenatal Actor PE | −0.16 | .02 | −0.30 | −0.02 | .13 | |
Prenatal Partner PE | −0.01 | .93 | −0.14 | 0.13 | .01 | |
Gender | 0.14 | .57 | −0.36 | 0.65 | .04 | |
Prenatal Actor PE x Gender | −0.01 | .93 | −0.15 | 0.14 | .01 | |
Prenatal Partner PE x Gender | −0.02 | .75 | −0.17 | 0.12 | .02 |
Note. Focal effects that were statistically significant are highlighted in bold.